glutathione and triple negative breast cancer

glutathione and triple negative breast cancer GSTP1 Is a Driver of Triple-Negative Cell Metabolism Pathogenicity A review of biological targets

Name: glutathione and triple negative breast cancer GSTP1 Is a Driver of Triple-Negative Cell Metabolism Pathogenicity A review of biological targets
Brand: iglepidom.org
SKU: 58106076572
Price: 25.44 USD
Availability: InStock
Rating: 4.3114 (19 reviews)

A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Oncology Letters Mitochondrial Redox Vulnerabilities in Triple Negative Breast Cancer: Integrative Perspectives and Emerging Therapeutic Strategies A scheme of the mechanism of CHAC1 degradation of glutathione enhancing Download Scientific Diagram

SKU: 58106076572 · From iglepidom.org

4.3

USD25.44 USD54.44

Pay in 4 interest-free payments of $6.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

M.WrzosekL.BoschatL.BruneauA.FerrereG.et al (2016)

Ozone IV Therapy: Advanced Healing with Ozone Therapy

J Enzyme Inhib Med Chem 30(2):264269 eker Karatoprak G, Dumlupnar B, Celep E, Kurt Celep I, Kpeli Akkol E, Sobarzo-Snchez E (2024) A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers